MetalDrug is a logic-first platform built to simulate, stress-test, and structure molecular behaviors through a controlled, tiered simulation interface. No black boxes. No brute force.
Most platforms guess. We build structured simulations based on interaction logic—across redox states, pH variations, and electrostatic dynamics. Every outcome can be traced back to logical blueprints.
Our system is powered by a multi-state verification core and programmable modeling layers that allow therapeutic logic to be refined iteratively across use cases.
Coordinate-driven compound design with energy-state control and binding stability prediction.
Peptide, RNA, and ligand-based logic modeling for programmable biochemistry and low-error therapeutic constructs.
All models run within access-controlled, review-enabled logic environments. No open-ended AI. No uncontrolled generation.
Request access to advanced blueprint validation and programmable molecular testing via our secure logic interface. Designed for scientific clarity, regulatory alignment, and innovation at the frontier.
Request Tiered AccessA next-generation platform using metal coordination chemistry and SEI-driven inference to design programmable therapeutics.
Discover how our core technology reprograms therapeutic behavior via metal-ligand frameworks. Dive into the chemistry behind MDC and its programmable logic design.
Read the Technology Overview →Moleculogic enables interactive blueprint validation, entropy scoring, and metal-drug coordination simulation. Explore both public previews and secure sandbox tools.
Moleculogic now supports FDC—ligands, peptides, RNAs, and protein-based designs. FDC logic expands drug programming to include non-metal coordination and biologically guided simulation.
Explore Moleculogic FDC Tier 0 (Public Introduction)Biopharma, academic researchers, synthetic biology startups, and drug delivery engineers. See how MDC adapts to your domain.
View Stakeholder Alignment →Flexible models for therapeutic IP, including drug-by-drug licenses and MDC-as-a-Service. Milestone-based terms and white-label molecular infrastructure available.
MDC's and FDC's compounds are in preclinical and early validation stages across antiviral, neurochemical, and regulatory applications.
See the Pipeline →Explore published results, data sets, and AI validation protocols. Controlled reviewer access under NDA is available.
Browse Publications →